Preclinical Research
Total Trials
20
As Lead Sponsor
13
As Collaborator
7
Total Enrollment
18,048
NCT01095822
Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics
Phase: Phase 4
Role: Lead Sponsor
Start: Mar 31, 2010
Completion: Mar 31, 2011
NCT01086163
Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
Phase: N/A
Start: Oct 31, 2010
Completion: Apr 30, 2011
NCT02195063
Survey Study for Pain Management, Wound Care, Scar Care or UDT
Role: Collaborator
Start: Nov 30, 2013
Completion: Not specified
NCT03956433
Effect of Bioactive Enriched Food on Markers of Metabolic Syndrome
Start: Sep 1, 2014
Completion: Jul 4, 2015
NCT02424500
Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy
Start: Jan 31, 2015
Completion: Jun 30, 2017
NCT06092840
Effect of Transform Burn on Weight Loss
Start: Mar 23, 2016
Completion: Sep 1, 2016
NCT06248788
Salivary Immunoglobulin A (sIgA) Normal Range Study
Start: Jun 19, 2017
Completion: Jan 20, 2018
NCT03108469
Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine
Phase: Phase 2
Start: Aug 1, 2017
Completion: Apr 26, 2019
NCT05130905
RiteStart Personal Nutritional Dietary Study
Start: Sep 1, 2017
Completion: Dec 20, 2017
NCT03337620
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
Phase: Phase 3
Start: Sep 20, 2017
Completion: Dec 29, 2023
NCT05476406
Clinical Study to Evaluate the Impact of aKwa Skincare System on Skin Health
Start: Apr 11, 2019
Completion: Jul 26, 2019
NCT04366921
European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO
Start: Apr 10, 2020
Completion: Apr 30, 2022
NCT05347602
Gold Factor on Knee Joint Health and Function
Start: Aug 3, 2020
Completion: Dec 30, 2020
NCT04465357
Efficacy of Erenumab on Functional Impact of Migraine
Start: Oct 22, 2020
Completion: Jun 3, 2022
NCT04837651
Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab
Start: Mar 2, 2021
Completion: Jul 1, 2021
NCT05026216
To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite.
Start: Mar 29, 2021
Completion: Aug 31, 2021
NCT06218199
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Start: Jul 8, 2021
Completion: Dec 31, 2026
NCT05368909
Clinical Study to Assess a Dietary Supplement on Sleep Health and Quality
Start: Dec 16, 2021
Completion: May 31, 2022
NCT07106879
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
Start: Jul 30, 2025
Completion: Dec 1, 2030
Loading map...